Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  MannKind Corporation    

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

MannKind Corporation : MNKD, MU, ALXN and GMCR added to NASDAQ Active Stock Watch List at EPR

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/16/2013 | 03:05pm CEST

New York, NY - (ACCESSWIRE) - 07/16/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding MannKind Corp. (NASDAQ:MNKD), Micron Technology Inc. (NASDAQ:MU), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR),

MannKind Corp. (NASDAQ:MNKD) a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States closed up in its previous session (+6.47%) on 7,469,136 shares traded. MannKind Corp. (NASDAQ:MNKD) is currently up (+310.99%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about MannKind Corp. (NASDAQ:MNKD)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MNKD&SubId=AW

Micron Technology Inc. (NASDAQ:MU) a company that together with its subsidiaries, engages in manufacturing and marketing semiconductor devices worldwide closed up in its previous session (+2.99%) on 29,731,748 shares traded after Micron Technology Inc reported its Financials. Micron Technology Inc. (NASDAQ:MU) is currently up (+155.62%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Micron Technology Inc. (NASDAQ:MU)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MU&SubId=AW

Also mentioned in Equity Profile Report?s NASDAQ Active Stock Watch List and Investor Poll was: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR), Groupon, Inc. (NASDAQ:GRPN) and Zynga, Inc. (NASDAQ:ZNGA)

To see what other investors are saying about: ALXN, GMCR, GRPN, ZNGA

Click here: http://www.equityprofilereport.com/PR.aspx?stock=ALXN-GMCR-GRPN-ZNGA&SubId=AW

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:

Equity Profile Report

editor@Equityprofilereport.com


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MANNKIND CORPORATION
06/28 MannKind Draws Remaining Funds under Mann Group Loan Arrangement
06/15 MANNKIND : Foreign-Trade Zone (FTZ) 76--Danbury, Connecticut; Authorization of P..
06/11 NEW MANNKIND CEO : Afrezza, global markets are key to company's future
06/06 MANNKIND : Engages Locust Walk to Explore Strategic Options for MannKinds Non-in..
06/05 MANNKIND : Engages Locust Walk to Explore Strategic Options for MannKind's Non-i..
06/05 MannKind Engages Locust Walk to Explore Strategic Options for MannKind’..
06/01 MANNKIND CORP : Change in Directors or Principal Officers (form 8-K)
06/01 MANNKIND : and Biomm Enter Into Distribution Agreement for Afrezza in Brazil
06/01 MANNKIND : and Biomm Enter Into Distribution Agreement for Afrezza in Brazil
05/31 MANNKIND : Provides Update on Senior Management
More news
Sector news : Bio Therapeutic Drugs
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/20 Novartis eye drug works with fewer injections than rival
06/15DJACTELION : J&J Maps Research Plans for Actelion -- WSJ
06/14DJACTELION : Correction to J&J Actelion Story
06/14DJACTELION : J&J Plans to Add Drug Discovery and Early Research to Actelion Unit
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/06 Midday Gainers / Losers
03/06 HEALTHCARE - TOP GAINERS / LOSERS AS : 00 am
03/06 MannKind - Afrezza Sales Struggle As February Comes To A Close
03/03 MANNKIND ENACTS REVERSE SPLIT AT 1-F : What Investors Need To Consider
03/03 Post-split trading in MannKind commences today
Advertisement
Financials ($)
Sales 2017 12,0 M
EBIT 2017 -82,1 M
Net income 2017 -88,9 M
Finance 2017 176 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales 2017 -1,54x
Capi. / Sales 2018 7,50x
Capitalization 158 M
More Financials
Technical analysis trends MANNKIND CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 0,54 $
Spread / Average Target -65%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael E. Castagna Chief Executive Officer & Director
Kent Kresa Chairman
Rosabel Realica Alinaya Chief Financial & Accounting Officer
Raymond W. Urbanski Chief Medical Officer & Vice President
Joseph Kocinsky Chief Technology Officer & Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MANNKIND CORPORATION158
AMGEN16.85%125 643
CELGENE CORPORATION13.05%102 171
GILEAD SCIENCES-1.34%92 320
REGENERON PHARMACEUTIC..40.54%53 371
VERTEX PHARMACEUTICALS75.42%32 187
More Results